Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation.
about
Critical role of PI3K/Akt/GSK3β in motoneuron specification from human neural stem cells in response to FGF2 and EGFWnt signaling in myogenesisChromatin signaling in muscle stem cells: interpreting the regenerative microenvironmentMolecular profiles of Quadriceps muscle in myostatin-null mice reveal PI3K and apoptotic pathways as myostatin targets.Prolonged activation of S6K1 does not suppress IRS or PI-3 kinase signaling during muscle cell differentiation.Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kappaB signaling.Protein kinase G1 α overexpression increases stem cell survival and cardiac function after myocardial infarction.Skeletal muscle mass recovery from atrophy in IL-6 knockout mice.Insulin and LiCl synergistically rescue myogenic differentiation of FoxO1 over-expressed myoblastsInhibition of glycogen synthase kinase-3β attenuates glucocorticoid-induced suppression of myogenic differentiation in vitro.Wnt/β-catenin controls follistatin signalling to regulate satellite cell myogenic potential.Suppression of GSK-3β activation by M-cadherin protects myoblasts against mitochondria-associated apoptosis during myogenic differentiationWnt7a-Fzd7 signalling directly activates the Akt/mTOR anabolic growth pathway in skeletal muscle.FOXO1 and GSK-3β Are Main Targets of Insulin-Mediated Myogenesis in C2C12 Muscle Cells.Differential regulation of the histone chaperone HIRA during muscle cell differentiation by a phosphorylation switch.IGF-I activates the mouse type IIb myosin heavy chain gene.Notch and Wnt signaling, physiological stimuli and postnatal myogenesisThe myogenic kinome: protein kinases critical to mammalian skeletal myogenesis.Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies.Wnt/β-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells.The ubiquitin proteasome system in atrophying skeletal muscle: roles and regulation.Lithium chloride attenuates cell death in oculopharyngeal muscular dystrophy by perturbing Wnt/β-catenin pathway.Synergistic stimulation of myogenesis by glucocorticoid and IGF-I signaling.Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.Segregation of myoblast fusion and muscle-specific gene expression by distinct ligand-dependent inactivation of GSK-3β.Glycogen synthase kinase 3beta is a novel regulator of high glucose- and high insulin-induced extracellular matrix protein synthesis in renal proximal tubular epithelial cellsGlycogen synthase kinase 3 suppresses myogenic differentiation through negative regulation of NFATc3.IRS4, a novel modulator of BMP/Smad and Akt signalling during early muscle differentiation.Fast-degradable microbeads encapsulating human umbilical cord stem cells in alginate for muscle tissue engineering.Myogenic differentiation of muscular dystrophy-specific induced pluripotent stem cells for use in drug discovery.Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: II. Effects on skeletal muscle atrophy.GSK3β inhibition and LEF1 upregulation in skeletal muscle following a bout of downhill running.Survival-apoptosis associated signaling in GNE myopathy-cultured myoblasts.Lithium chloride regulates connexin43 in skeletal myoblasts in vitro: possible involvement in Wnt/beta-catenin signaling.Adaptive responses of TRPC1 and TRPC3 during skeletal muscle atrophy and regrowth.Efficient transdifferentiation of human dermal fibroblasts into skeletal muscle.Detection of genomic structural variations in Guizhou indigenous pigs and the comparison with other breeds.
P2860
Q21090994-1DD6941D-E38A-422E-972B-888C7FC37544Q26991558-D7757A58-2590-49AD-AAC5-C706D236BF2DQ28083474-66EE6979-7CB7-4D32-82EB-F06EAC42C825Q33435677-1E169C00-3354-402A-91CE-FB771A1EB71CQ33589341-B07237F7-1A9D-4D98-8E61-1EF286DD1563Q33710814-8B0A8720-0F7E-403E-8455-071CAAD8954AQ34639920-CB9F3DA9-4854-4053-AD0B-69F0EEF611ADQ35085611-1A75FE37-160A-4018-B043-774FCAAC6739Q35097402-E287EF48-96F1-471B-A85C-F12C1EFCE5F2Q35225779-20185A6C-BBA2-443B-A916-13DE906DAE7EQ35575301-658E2991-873C-434B-B5ED-36C2D95F7E51Q35576461-5DF46852-3D60-479F-9EBE-2D5158085124Q35729957-957997C7-B8EC-40F3-A9BE-A422144D9DC3Q35897895-05243630-D449-4FB9-A218-0867A8BF19B7Q37223761-27278E5B-E67B-493E-8D4D-9F4AE72187AEQ37406259-D098041B-72F3-48F8-A494-B659C1942C01Q37766757-E806788A-623A-48EF-BD6A-F023A3D7268FQ37929319-3280CDE6-2E27-4281-8860-28D07544A083Q37963087-F4C6EEE9-9D33-4BDB-8CDB-FA050C8E9008Q38449008-7AE41180-5796-4DF5-BEA9-DE5108224E18Q38924199-858E231D-766C-4F04-A9A4-A8D5CB55277FQ39087896-A40694D6-0760-42D1-AB1A-A42E6EA7E302Q39242632-B093E98D-6318-48B2-8E15-B59DD5C0F48EQ39492090-39412580-A191-47DE-AB32-8B191F743E9EQ39669643-F7C9D97A-2E93-4273-A085-5C327F553E63Q39950939-0E741415-143B-4ECC-BEF4-9B7ED41D7810Q40058218-BA4AF4FC-0D26-4A9D-979B-EA225B0E9639Q41458783-21A73237-EB4F-45E6-BF17-9ED3E8D96B17Q41672087-0E4A7FF6-B80E-40FB-81ED-1D8F28B06909Q41956611-B56BF16C-149E-4FD5-89C2-2D90DD85656DQ42011965-E110F1B4-C232-49A5-A505-725D8AFFE08EQ44957259-A19070A7-DB99-490D-B240-2E36E4DA201BQ45871239-874B905E-D4A5-4E94-9B10-D6CE3F38AE77Q46274775-8719BD9A-F04A-428F-91A2-1719720FF1F5Q48008913-65D19BC3-CE87-40B9-BF12-4491F7348D0EQ48336711-41298156-7E9A-44A4-A18C-28DAA7F8CFA3Q55175432-75F21BDC-EC22-40BD-B1C3-3CD9AC610E32
P2860
Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Inhibition of glycogen synthas ...... late myogenic differentiation.
@en
type
label
Inhibition of glycogen synthas ...... late myogenic differentiation.
@en
prefLabel
Inhibition of glycogen synthas ...... late myogenic differentiation.
@en
P2093
P2860
P50
P1476
Inhibition of glycogen synthas ...... late myogenic differentiation.
@en
P2093
Jos L J van der Velden
Marco C J M Kelders
Ramon C J Langen
P2860
P304
P356
10.1152/AJPCELL.00068.2005
P577
2005-09-14T00:00:00Z